Azzad Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Azzad Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Buy	+4,784	New	+$360K	0.03%	322
2018 Q4	–	Sell	-8,451	Closed	-$436K	–	310
2018 Q3	$436K	Hold	8,451	–	–	0.12%	255
2018 Q2	$352K	Buy	8,451 +664	+9%	+$29.4K	0.1%	269
2018 Q1	$343K	Buy	7,787 +400	+5%	+$20.3K	0.1%	257
2017 Q4	$372K	Hold	7,387	–	–	0.12%	241
2017 Q3	$375K	Hold	7,387	–	–	0.13%	234
2017 Q2	$376K	Buy	+7,387	New	+$344K	0.13%	226

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Azzad Asset Management's IONS Position: Q2 2026 in Review

Azzad Asset Management opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 4,784 shares worth $379K. The stake represents 0.03% of the portfolio and ranks #322 among its holdings. This is a return to the name: Azzad Asset Management previously reported a position in IONS as recently as Q3 2018.

Azzad Asset Management first reported a position in IONS in Q2 2017 and has held it in 7 quarters since. The position peaked at $436K in Q3 2018. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Azzad Asset Management held 4,784 shares of Ionis Pharmaceuticals worth $379K as of Q2 2026.
Ionis Pharmaceuticals was a new Azzad Asset Management position in Q2 2026.
Ionis Pharmaceuticals made up 0.03% of Azzad Asset Management's portfolio in Q2 2026, its #322 holding.
Azzad Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 7 quarters since.
Azzad Asset Management's Ionis Pharmaceuticals position peaked at $436K in Q3 2018.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.